ADHD is a neurodevelopmental condition marked by persistent inattention, hyperactivity, and impulsivity that impacts daily functioning (National Institute of Mental Health, 2024). Globally, it affects about 8% of children and 2.6–6.8% of adults (Ayano, 2023), with significant effects on academic, occupational, and social spheres, often leading to emotional distress (Ben-Dor Cohen, 2021). You may experience amplified symptoms during menstrual cycles, perimenopause, or postpartum periods due to hormonal shifts.
This protocol provides practical guidance on labs, supplements, and lifestyle strategies to help our providers design tailored plans for you seeking to manage ADHD’s underlying mechanisms.
Comprehensive lab testing at ELEVATEHER uncovers potential root causes. Food sensitivity tests identify inflammatory triggers, enabling elimination diets that may alleviate symptoms (Yorgidis, 2021). Heavy metal panels assess exposures like lead or mercury that affect neural function (Lee, 2018). Hormone and neurotransmitter evaluations detect imbalances linked to ADHD (Roberts, 2018); (da Silva, 2023). Micronutrient screens address deficiencies common in ADHD, supporting brain health (Villagomez, 2014).
We acknowledge that FDA-approved medications can play a key role in an integrated treatment plan, particularly when symptoms significantly impair daily functioning. As of 2026, approved medications fall into two main categories: stimulants, such as methylphenidate-based (e.g., Ritalin, Concerta) and amphetamine-based (e.g., Adderall, Vyvanse) products, which enhance dopamine and norepinephrine activity; and non-stimulants, including atomoxetine (Strattera), viloxazine (Qelbree), extended-release guanfacine (Intuniv), and extended-release clonidine (Kapvay), which offer alternatives for those who do not respond well to or cannot tolerate stimulants. We consider individual patient factors, including comorbidities and potential side effects, and monitor closely, especially in women where hormonal interactions may influence efficacy.
We recommend evidence-based supplements to complement treatments by restoring nutrients, balancing neurotransmitters, and curbing inflammation. Selections are based on clinical evidence for ADHD outcomes.
Lifestyle changes form the foundation of our protocols, targeting neurocognitive health and comorbidities like anxiety or sleep issues prevalent in women with ADHD.
To build a personalized ADHD plan, we may suggest the following tests to identify contributing factors:
These are crucial for women, as hormonal imbalances can exacerbate ADHD symptoms during cycles or life transitions.
Deficiencies in these nutrients are common in ADHD and can impair neurotransmitter synthesis.
Our supplement recommendations are age-specific, with a focus on safety and efficacy. Always consult with our providers for personalization, especially for women who are pregnant, breastfeeding, or on medications. You can see the whole list of third party tested supplements here.
At Elevate Her Health, we prioritize lifestyle as a cornerstone for managing ADHD, tailored to women’s unique needs.
Adopt an anti-inflammatory diet like Mediterranean or DASH to reduce ADHD risk by 37% (Pinto, 2022). Emphasize:
Avoid triggers: Artificial dyes (OEHHA, 2021), aspartame (Jones, 2023), gluten (Honar, 2022), dairy (Lange, 2023), identified sensitivities (Yorgidis, 2021), and Western diets (Del-Ponte, 2019).
Exercise benefits cognition and behavior (Ng, 2017). Recommend mixed programs:
Address stress to mitigate ADHD severity (Koppelmaa, 2024); (Robinson, 2024). Use:
Tackle common sleep issues in ADHD (Surman, 2021); (Sciberras, 2022). Recommendations:
For personalized consultations, visit elevateherhealth.com or contact our Santa Barbara office. This protocol is for informational purposes; always seek professional advice.